Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Hydrocortisone for Term Hypotension

ClinicalTrials.gov ID: NCT01954056

Public ClinicalTrials.gov record NCT01954056. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Hydrocortisone Treatment of Cardiovascular Insufficiency in Term and Late Preterm Infants: A Randomized Controlled Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial will evaluate the effects of a 7-day course of hydrocortisone therapy on short-term morbidity, cardiovascular function, long-term neurodevelopment, and mortality in critically ill, term and late preterm infants diagnosed with cardiovascular insufficiency as defined by a need for inotrope therapy in the first 72 hours of age.

Study identification

NCT ID
NCT01954056
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
12 participants

Conditions and interventions

Eligibility (public fields only)

Age range
34 Weeks and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2014
Primary completion
Mar 19, 2018
Completion
Mar 19, 2018
Last update posted
Jul 5, 2021

2014 – 2018

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
University of California - Los Angeles Los Angeles California 90025
Stanford University Palo Alto California 94304
Emory University Atlanta Georgia 30303
Indiana University Indianapolis Indiana 46202
University of Iowa Iowa City Iowa 52242
Wayne State University Detroit Michigan 48201
Children's Mercy Hospital Kansas City Missouri 64108
University of New Mexico Albuquerque New Mexico 87131
University of Rochester Rochester New York 14642
RTI International Durham North Carolina 27705
Duke University Durham North Carolina 27710
Cincinnati Children's Medical Center Cincinnati Ohio 45267
Case Western Reserve University Cleveland Ohio 44106
Research Institute at Nationwide Children's Hospital Columbus Ohio 43205
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235
University of Texas Health Science Center at Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01954056, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2021 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01954056 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →